Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk
Completed · Phase 4
Conditions studied: HIV, Contraception
In brief
This is a prospective cohort study focusing on HIV negative women. The investigators want to learn how the contraceptive methods of depot medroxyprogesterone acetate (DMPA), etonogestrel implant (Eng-Implant), levonorgestrel intrauterine device (Lng-IUD) and the ParaGard® T 380A Intrauterine Copper Contraceptive impact the vaginal immune environment.
Key facts
- Study ID
- NCT02357368
- Run by
- Lisa Haddad
- People needed
- 59
- Starts
- 2015-02-01
- Expected to finish
- 2019-10-23
- Last updated by the study team
- 2020-11-18
Who can join
Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Female
- Age 18-45 years
- Normal menses (22-35 day intervals) for at least 3 cycles
- Intact uterus and cervix
- Interested in to DMPA, Eng-Implant or Lng-IUD or ParaGuard
- Willing to delay initiation of hormonal contraception for up to 1 month
- Willing to use condoms or abstain from sexual intercourse for at least 48 hours before each genital tract sampling (condoms will be made available)
- Able and willing to provide informed consent, and undergo serial blood and cervicovaginal lavage (CVL) sampling
- Negative HIV screening
You may not qualify if…
- Pregnant within the last 3 months
- Breastfeeding
- History of loop electrosurgical excision procedure, conization, or cryosurgery within the past year
- Use of hormonal contraception or IUD in the past 6 months
- Known history of medical condition that would interfere with the conduct of the study
- Symptomatic vaginal infection or genital ulcer disease at screening
- Taking medications that interact with selected contraceptive
- Contraindications to selected contraceptive per the Centers for Disease Control and Prevention (CDC) medical eligibility criteria or judgment of clinician
Where it is running
- Grady Health System — Atlanta, Georgia, United States
- The Ponce de Leon Center of the Grady Health System — Atlanta, Georgia, United States
- Emory Clinic — Atlanta, Georgia, United States
- Emory University Clinical Research Network — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.